Revenue: The sum of all revenue fields included for a company's operating activities.
CASI Pharmaceuticals Inc. (CASI) had Revenue of $4.17M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$4.17M |
$-13.38M |
|
$2.12M |
|
$2.06M |
|
$15.30M |
|
$-11.12M |
|
$-0.08M |
|
$-11.20M |
|
$-11.20M |
|
$-11.20M |
|
$-13.38M |
|
$-13.38M |
|
$-11.20M |
|
$-11.12M |
|
$-11.12M |
|
15.51M |
|
15.51M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$18.16M |
|
$7.40M |
|
$13.04M |
|
$31.20M |
|
$37.74M |
|
-- |
|
$13.78M |
|
$51.51M |
|
$-20.31M |
|
$-20.54M |
|
$-20.31M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.48 |
|
-- |
|
-- |
|
-- |
|
-0.92 |
|
49.29% |
|
-266.47% |
|
-266.47% |
|
-- |
|
-268.29% |
|
-320.36% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.62 |
|
0.78 |
|
115.61 |
|
65.85% |
|
65.12% |
|
-42.87% |
|
65.85% |
|
-- |
|
-- |
|
-- |
|